Clinical Trial Update: Integrated Biomarker And Imaging Study - 2 [Phase 2]

View source ↗

Summary

Phase 2 integrated biomarker and imaging study in atherosclerosis; results have been posted (completed in 2018).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 2 | Status: COMPLETED | Results posted: 2018-02-19